The IGF1 signaling pathway: from basic concepts to therapeutic opportunities

H Werner - International journal of molecular sciences, 2023 - mdpi.com
Insulin-like growth factor 1 (IGF1) is a peptide growth factor with important functions in
multiple aspects of growth, development and metabolism. The biological actions of IGF1 are …

The role of IGF/IGF-1R signaling in hepatocellular carcinomas: stemness-related properties and drug resistance

MHT Ngo, HY Jeng, YC Kuo, JD Nanda… - International journal of …, 2021 - mdpi.com
Insulin-like Growth Factor (IGF)/IGF-1 Receptor (IGF-1R) signaling is known to regulate stem
cell pluripotency and differentiation to trigger cell proliferation, organ development, and …

[HTML][HTML] Function of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy

J Yuan, Z Yin, K Tao, G Wang, J Gao - Oncology letters, 2018 - spandidos-publications.com
Drug resistance is a primary cause of chemotherapeutic failure; however, how this
resistance develops is complex. A comprehensive understanding of chemotherapeutic …

MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1

Z Niu, T Han, X Sun, L Luan, W Gou, X Zhu - American journal of obstetrics …, 2018 - Elsevier
Objective Preeclampsia (PE) affects many women globally and remains a primary cause of
neonatal and maternal morbidity and mortality. Aberrant placental microRNA (miRNA) …

Genomics and the immune landscape of osteosarcoma

CC Wu, JA Livingston - Current Advances in the Science of Osteosarcoma …, 2020 - Springer
Conventional osteosarcoma (OS) is a high-grade intraosseous malignancy with production
of osteoid matrix; however, a deeper dive into the underlying genetics reveals genomic …

Noncoding RNAs in the glycolysis of ovarian cancer

C Zhang, N Liu - Frontiers in Pharmacology, 2022 - frontiersin.org
Energy metabolism reprogramming is the characteristic feature of tumors. The
tumorigenesis, metastasis, and drug resistance of ovarian cancer (OC) is dependent on …

MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy

J Matuszyk - Molecular Medicine, 2022 - Springer
Background The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several
types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene …

Role of the GH-IGF1 system in progression of cancer

H Werner, Z Laron - Molecular and Cellular Endocrinology, 2020 - Elsevier
Emerging evidence links the growth hormone (GH)-insulin-like growth factor-1 (IGF1)
endocrine axis to cancer development. While this putative correlation is of major …

Hepatocyte deletion of IGF2 prevents DNA damage and tumor formation in hepatocellular carcinoma

D Kumar, M Das, A Oberg, D Sahoo, P Wu… - Advanced …, 2022 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Serine‐
arginine rich splicing factor 3 (SRSF3) plays a critical role in hepatocyte function and its loss …

Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

H Werner, R Sarfstein, I Bruchim - Expert opinion on investigational …, 2019 - Taylor & Francis
Introduction: The insulin-like growth factors (IGFs) are a family of secreted peptide hormones
with important roles in different cellular and organism functions. The biological activities of …